Trial Profile
A Comparative, Single Center, Randomized, Double-blinded, Parallel, Placebo-controlled Study to Evaluate the Efficacy of Nabilone (Cesamet) as Adjunctive Therapy to Gabapentin (Neurontin) in the Management of Neuropathic Pain (NPP) Symptoms in Subjects With Multiple Sclerosis (MS).
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 May 2019
Price :
$35
*
At a glance
- Drugs Nabilone (Primary) ; Gabapentin
- Indications Neuropathic pain
- Focus Therapeutic Use
- 26 Jul 2012 Actual end date (1 Jul 2012) added as reported by ClinicalTrials.gov.
- 01 Jul 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 22 Oct 2011 Results presented at the 27th Congress of the European Committee for Treatment and Research in Multiple Sclerosis.